Stockscreener 앱 받기
2.35
2.62%
0.06
시간 외 거래:
2.35
전일 마감가:
$2.29
열려 있는:
$2.24
하루 거래량:
3.17M
Relative Volume:
0.64
시가총액:
$113.06M
수익:
-
순이익/손실:
$-97.22M
주가수익비율:
-1.0731
EPS:
-2.19
순현금흐름:
$-82.44M
1주 성능:
-14.55%
1개월 성능:
-90.98%
6개월 성능:
-88.24%
1년 성능:
-91.53%
1일 변동 폭
$2.23
$2.41
1주일 범위
$2.23
$2.83
52주 변동 폭
$2.23
$42.20
카사바 Stock (SAVA) Company Profile
명칭
Cassava Sciences Inc
전화
512-501-2444
주소
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
SAVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SAVA
Cassava Sciences Inc
|
2.35 | 113.06M | 0 | -97.22M | -82.44M | -2.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
카사바 Stock (SAVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | 재확인 | Maxim Group | Buy |
| 2021-04-27 | 개시 | B. Riley Securities | Buy |
| 2021-02-16 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-09-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-01-10 | 재확인 | Maxim Group | Buy |
모두보기
카사바 주식(SAVA)의 최신 뉴스
CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassav - The Malaysian Reserve
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesSAVA - PR Newswire
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Cassava - GlobeNewswire
Class Action Filed Against Cassava Sciences, Inc. (SAVA)February 10, 2025 Deadline to JoinContact The Gross Law Firm - Longview News-Journal
Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors - GlobeNewswire
SAVA Stock Plummets to 52-Week Low at $2.33 Amid Market Challenges - Investing.com
SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit - The Malaysian Reserve
SAVA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava - PR Newswire
CASSAVA SCIENCES, INC. (NASDAQ: SAVA) INVESTOR ALERT: - GlobeNewswire
CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - GlobeNewswire Inc.
CASSAVA ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Cassava - GlobeNewswire
SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Levi & Korsinsky Notifies Cassava Sciences, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSAVA - Longview News-Journal
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Cassava Sciences, Inc. - PR Newswire
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Cassava Sciences, Inc. - EIN News
Cassava Sciences, Inc. Sued for Securities Law Violations – - GlobeNewswire
The Manufacturers Life Insurance Company Sells 7,458 Shares of Cassava Sciences, Inc. (NASDAQ:SAVA) - Defense World
Cassava Sciences, Inc. (NASDAQ:SAVA) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
SAVA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cassava - GlobeNewswire
SAVA Investors with Losses in Excess of $100K Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit - The Malaysian Reserve
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights - The Bakersfield Californian
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
375,000 Shares in Cassava Sciences, Inc. (NASDAQ:SAVA) Bought by Tidal Investments LLC - MarketBeat
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors - GlobeNewswire
Lost Money on Cassava Sciences, Inc.(SAVA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky LLP - TipRanks
Cassava Shares Sink as CEO Resigns From Troubled Biotech Company - MSN
SAVA Stock Plummets to 52-Week Low at $2.77 Amid Market Challenges By Investing.com - Investing.com South Africa
SAVA Stock Plummets to 52-Week Low at $2.77 Amid Market Challenges - Investing.com India
RIP simufilam, we hardly knew ye - Healthcare Brew
Bronstein, Gewirtz & Grossman, LLC Is Investigating Cassava Sciences, Inc. (SAVA) And Encourages Shareholders to Connect - AccessWire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Cassava Sciences, Inc. (SAVA) And Encourages Shareholders to Reach Out - AccessWire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cassava Sciences, Inc. (SAVA) and Encourages Shareholders to Learn More About the Investigation - AccessWire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cassava Sciences, Inc. (SAVA) and Encourages Investors to Learn More About the Investigation - AccessWire
Cassava Sciences, Inc. (SAVA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire
Cassava Sciences Stock Craters After Alzheimer’s Disease Trial Flops: Retail’s Devastated - MSN
SAVA Stock Plummets to 52-Week Low at $3.35 Amid Market Turbulence By Investing.com - Investing.com South Africa
SAVA Stock Plummets to 52-Week Low at $3.35 Amid Market Turbulence - Investing.com India
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc.SAVA - PR Newswire
Cassava Sciences: REFOCUS Unlikely To Save Simufilam, Careful Development Needed - Seeking Alpha
A Post-Mortem on Cassava Sciences - MSN
Down -83.93% in 4 Weeks, Here's Why You Should You Buy the Dip in Cassava Sciences (SAVA) - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Cassava Sciences, Inc. (SAVA) And Encourages Stockholders to Reach Out - AccessWire
HC Wainwright Has Negative Outlook of SAVA FY2024 Earnings - MarketBeat
카사바 (SAVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
카사바 주식 (SAVA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Option Exercise |
1.18 |
50,000 |
59,000 |
71,300 |
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Sale |
3.86 |
59,800 |
230,828 |
11,500 |
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Sale |
3.82 |
2,000 |
7,640 |
0 |
2.88%
2.65%
자본화:
|
볼륨(24시간):